Sinclair Pharma

Equity Alert Sinclair Pharma plc Period End 30 June 2009

Submitted by Company Reporting on Fri, 2010-02-19 12:15

Sinclair Pharma
Listed
United Kingdom
Research & development
4500 Health Care
4570 Pharmaceuticals & Biotechnology
4577 Pharmaceuticals
4000 Health Care
Yellow Alert

Sinclair Pharma plc Period End 30 June 2009

Submitted by Company Reporting on Fri, 2010-02-19 10:37

Sinclair Pharma
Listed
United Kingdom
Associated undertakings
Deferred tax
Going concern assumption
IAS 12 'Income taxes'
IAS 24 'Related party disclosures'
IAS 28 'Investments in associates'
IAS 37 'Provisions, contingent liabilities and contingent assets'
IAS 38 'Intangible assets'
Provisions
Related party transactions
Research and development
Segmental information
4500 Health Care
4570 Pharmaceuticals & Biotechnology
4577 Pharmaceuticals
4000 Health Care

Exclusion of salary costs from research and development expenditure conflicts with IFRS
UK pharmaceutical company Sinclair Pharma excludes salary costs from its research and development expenditure in treatment that conflicts with IFRS.

Add new comment